M&A Deal Summary

Bracco Imaging Acquires Blue Earth Diagnostics

On June 27, 2019, Bracco Imaging acquired medical products company Blue Earth Diagnostics for 475M USD

Acquisition Highlights
  • This is Bracco Imaging’s 1st transaction in the Medical Products sector.
  • This is Bracco Imaging’s largest (disclosed) transaction.
  • This is Bracco Imaging’s 1st transaction in the United Kingdom.

M&A Deal Summary
Date 2019-06-27
Target Blue Earth Diagnostics
Sector Medical Products
Buyer(s) Bracco Imaging
Deal Type Add-on Acquisition
Deal Value 475M USD

Target

Blue Earth Diagnostics

Oxford, United Kingdom
Blue Earth Diagnostics Ltd. is a healthcare company, provides Axumin® (fluciclovine F 18) injection is a novel molecular imaging agent approved in the United States and the European Union for use in PET imaging for men with suspected recurrent prostate cancer.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Bracco Imaging

Milan, Italy
Category Company
Sector Healthcare Services
DESCRIPTION

Bracco Imaging S.p.A. is a manufacturer and marketer of imaging solutions.

DEAL STATS #
Overall 2 of 2
Sector (Medical Products) 1 of 1
Type (Add-on Acquisition) 2 of 2
Country (United Kingdom) 1 of 1
Year (2019) 1 of 1
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-08-01 SMC-Swiss Medical Care SA

Lausanne, Switzerland

SMC-Swiss Medical Care SA is a manufacturer, researcher and marketer of automated delivery systems for the administration of contrast agents for diagnostic imaging.

Buy -
Mergr

Product

Company

Legal